To our knowledge, this is the first time that the six-transmembrane epithelial antigen of prostate 4 (STEAP4) which emerged from our screening efforts is linked to BC, and provides a novel pharmacological target with potential clinical translation. The gene discussed is STEAP4; the disease is breast cancer.